15hon MSN
One in three Australians with inflammatory bowel disease (IBD) left their medical consultations with misunderstandings about ...
The following is a summary of "AI-driven Personalized Medicine: Transforming Clinical Practice in Inflammatory Bowel Disease, ...
With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...
12h
Investor's Business Daily on MSNEldorado Gold Sees IBD RS Rating Improve To 73In a welcome move, Eldorado Gold saw its Relative Strength Rating rise from 69 to 73 on Thursday. Please watch the video at ...
12h
Investor's Business Daily on MSNU.S. Lime & Minerals Earns IBD Rating UpgradeU.S. Lime & Minerals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...
An increasing number of individuals experience discomfort in the gut or are being diagnosed with intestinal conditions such ...
A new study finds that gastrointestinal and psychological symptoms significantly impact disease activity in spondyloarthritis patients, highlighting the need for interdisciplinary care.
Organovo Holdings, Inc. (Nasdaq: ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease ...
Wolfe Research assumed coverage on shares of Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) in a research report issued ...
Bile duct inflammation and scarring, known as cholangiopathies, can disrupt bile flow, leading to liver damage and ...
Stocks opened lower on Thursday, but Wall Street bought the dip. The Dow was up 73 points, or 0.2%. The S&P 500 was up 0.3%. The Nasdaq Composite gained 0.4%. All three opened lower but popped in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results